These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37382724)

  • 1. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
    Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
    Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    Huang J; Cui W; Xie X; Lin K; Jin D; Xie X; Zhuang B
    Int J Hyperthermia; 2023; 40(1):2256498. PubMed ID: 37733400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
    Qiu ZC; Wu YW; Qi WL; Li C
    Cancer Med; 2024 Jan; 13(1):e6835. PubMed ID: 38130028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
    Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
    Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):903-911. PubMed ID: 35999514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
    Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
    BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional Analysis.
    Munir MM; Endo Y; Lima HA; Alaimo L; Moazzam Z; Shaikh C; Poultsides GA; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    J Gastrointest Surg; 2023 Mar; 27(3):544-554. PubMed ID: 36652178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC.
    Zhang ZQ; Xiong L; Zhou JJ; Miao XY; Li QL; Wen Y; Zou H
    World J Surg Oncol; 2018 Oct; 16(1):208. PubMed ID: 30326907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
    Luo H; Li C; Chen L
    Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
    Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
    Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy.
    Luo H; Huang C; Meng M; Zhang M; Li Z; Huang J
    BMC Gastroenterol; 2023 May; 23(1):162. PubMed ID: 37208618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiographic tumor burden score is useful for stratifying the overall survival of hepatocellular carcinoma patients undergoing resection at different Barcelona Clinic Liver Cancer stages.
    Li WF; Liu YW; Wang CC; Yong CC; Lin CC; Yen YH
    Langenbecks Arch Surg; 2023 May; 408(1):169. PubMed ID: 37121930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma.
    Lima HA; Endo Y; Moazzam Z; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Endo I; Kitago M; Shen F; Pawlik TM
    J Surg Oncol; 2023 Mar; 127(3):374-384. PubMed ID: 36194039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab-bevacizumab.
    Campani C; Bamba-Funck J; Campion B; Sidali S; Blaise L; Ganne-Carrié N; Demory A; Sutter O; Larrey E; Evain M; Ghannouchi H; Wagner M; Marra F; Sutton A; Allaire M; Nault JC
    Liver Int; 2023 Mar; 43(3):708-717. PubMed ID: 36444741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
    Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
    Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
    Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
    World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
    Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
    Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
    Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
    Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.
    Lima HA; Moazzam Z; Endo Y; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
    Ann Surg Oncol; 2023 Jun; 30(6):3363-3373. PubMed ID: 36820934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.